Journal of Virology

Journal

Publication Venue For

  • Dual pathways of human immunodeficiency virus type 1 envelope glycoprotein trafficking modulate the selective exclusion of uncleaved oligomers from virions.  95. 2021
  • Consequences of Phosphorylation in a Mononegavirales Polymerase-Cofactor System. 2021
  • Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes. 2021
  • Enterovirus infection induces massive recruitment of all isoforms of small cellular arf GTPases to the replication organelles.  95. 2021
  • Structural and functional characterization of host FHL1 Protein Interaction with Hypervariable Domain of Chikungunya Virus nsP3 Protein.  95. 2021
  • Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor.  94. 2020
  • Hypervariable domain of nsP3 of eastern equine encephalitis virus is a critical determinant of viral virulence.  94. 2020
  • BPIFB3 regulates endoplasmic reticulum morphology to facilitate flavivirus replication.  94. 2020
  • Long-Acting bms-378806 analogues stabilize the state-1 conformation of the human immunodeficiency virus type 1 envelope glycoproteins.  94. 2020
  • The Connector Domain of Vesicular Stomatitis Virus Large Protein Interacts with the Viral Phosphoprotein.  94. 2020
  • Cross-reactive CD8 T-cell responses elicited by adenovirus type 5-based HIV-1 vaccines contributed to early viral evolution in vaccine recipients who became infected.  94. 2020
  • Primary HIV-1 strains use nef to downmodulate HLA-E surface expression.  93. 2019
  • The guanine nucleotide exchange factor GBF1 participates in rotavirus replication.  93. 2019
  • BK Polyomavirus Activates the DNA Damage Response To Prolong S Phase.  93. 2019
  • A redundant mechanism of recruitment underlies the remarkable plasticity of the requirement of poliovirus replication for the cellular ArfGEF GBF1.  93. 2019
  • Defining HIV-1 envelope N-glycan microdomains through site-specific heterogeneity profiles.  93. 2019
  • Antisense-derived HIV-1 cryptic epitopes are not major drivers of viral evolution during the acute phase of infection.  92. 2018
  • Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.  92. 2018
  • Higher expectations for a vaccine to prevent congenital cytomegalovirus infection.  92. 2018
  • Multiple host factors interact with the hypervariable domain of chikungunya virus nsP3 and determine viral replication in cell-specific mode.  92. 2018
  • Novel insect-specific Eilat virus-based chimeric vaccine candidates provide durable, mono- and multivalent, single-dose protection against lethal alphavirus challenge.  92. 2018
  • β-D-N 4 -Hydroxycytidine is a potent anti-alphavirus compound that induces a high level of mutations in the viral genome.  92. 2018
  • Congenital Human Cytomegalovirus Infection and the Enigma of Maternal Immunity..  91. 2017
  • Attachment and postattachment receptors important for hepatitis C virus infection and cell-to-cell transmission.  91. 2017
  • Glycosylation benchmark profile for HIV-1 envelope glycoprotein production based on eleven Env trimers.  91. 2017
  • Tumor necrosis factor alpha-induced recruitment of inflammatory mononuclear cells leads to inflammation and altered brain development in murine cytomegalovirusinfected newborn mice.  91. 2017
  • φX174 procapsid assembly: Effects of an inhibitory external scaffolding protein and resistant coat proteins in vitro.  91. 2017
  • Superior efficacy of a human immunodeficiency virus vaccine combined with antiretroviral prevention in simian-human immunodeficiency virus-challenged nonhuman primates.  90. 2016
  • BPIFB6 Regulates Secretory Pathway Trafficking and Enterovirus Replication.  90:5098-5107. 2016
  • Characterization of simian immunodeficiency virus variants anatomically compartmentalized in plasma and milk in chronically infected African green monkeys.  90:8795-8808. 2016
  • Dynamics and correlates of CD8 T-cell counts in Africans with primary human immunodeficiency virus type 1 infection.  90:10423. 2016
  • Exploitation of interleukin-10 (IL-10) signaling pathways: Alternate roles of viral and cellular IL-10 in rhesus cytomegalovirus infection.  90:9920-9930. 2016
  • Structure and function of the N-terminal domain of the vesicular stomatitis virus RNA polymerase.  90:715-724. 2016
  • The SD1 subdomain of venezuelan equine encephalitis virus capsid protein plays a critical role in nucleocapsid and particle assembly.  90:2008. 2016
  • Epstein-Barr Virus Type 2 Latently Infects T Cells, Inducing an Atypical Activation Characterized by Expression of Lymphotactic Cytokines.  89:2301-2312. 2015
  • Association of HIV-1 envelope-specific breast milk IgA responses with reduced risk of postnatal mother-to-child transmission of HIV-1.  89:9952. 2015
  • Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.  89:3846-3858. 2015
  • Comparative analysis of the glycosylation profiles of membrane-anchored HIV-1 envelope glycoprotein trimers and soluble gp140.  89. 2015
  • In vivo activation of human NK cells by treatment with an interleukin-15 superagonist potently inhibits acute in vivo HIV-1 infection in humanized mice.  89:6264-6274. 2015
  • Stable phenotypic changes of the host T cells are essential to the long-term stability of latent HIV-1 infection.  89. 2015
  • The serum very-low-density lipoprotein serves as a restriction factor against hepatitis C virus infection.  89:6782-6791. 2015
  • The vaginal acquisition and dissemination of HIV-1 infection in a novel transgenic mouse model is facilitated by coinfection with herpes simplex virus 2 and is inhibited by microbicide treatment.  89:9559-9570. 2015
  • Global panel of HIV-1 env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies.  88:2489-2507. 2014
  • High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse.  88:2025-2034. 2014
  • Enhanced viral replication and modulated innate immune responses in infant airway epithelium following H1N1 infection.  88:7412. 2014
  • HIV-1 envelope glycan moieties modulate HIV-1 transmission.  88:14258. 2014
  • Higher-order structure of the rous sarcoma virus SP assembly domain.  88. 2014
  • Identification of nucleotide-level changes impacting gene content and genome evolution in orthopoxviruses.  88:13651-13668. 2014
  • Immune activation is associated with CD8 T cell interleukin-21 production in HIV-1-infected individuals.  88:10259-10263. 2014
  • Influenza virus infectivity and virulence following ocular-only aerosol inoculation of ferrets.  88:9647-9654. 2014
  • Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation.  88:364-376. 2014
  • Rewiring of cellular membrane homeostasis by picornaviruses.  88:9478-9489. 2014
  • Vaginal myeloid dendritic cells transmit founder HIV-1.  88:7683-7688. 2014
  • Vaccination against a virus-encoded cytokine significantly restricts viral challenge.  87:11323-11331. 2013
  • N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses.  87:8756-8766. 2013
  • Thiouracil cross-linking mass spectrometry: A cell-based method to identify host factors involved in viral amplification.  87:8697-8712. 2013
  • Comparison of the levels of infectious virus in respirable aerosols exhaled by ferrets infected with influenza viruses exhibiting diverse transmissibility phenotypes.  87:7864-7873. 2013
  • Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine.  87:6127-6136. 2013
  • Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes.  87:6866-6875. 2013
  • HIV-specific CD8+ T cells from elite controllers are primed for survival.  87. 2013
  • Venezuelan equine encephalitis virus nsP2 protein regulates packaging of the viral genome into infectious virions.  87:4202-4213. 2013
  • Hypervariable Domains of nsP3 Proteins of New World and Old World Alphaviruses Mediate Formation of Distinct, Virus-Specific Protein Complexes.  87:1997-2010. 2013
  • Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virus.  87:890-899. 2013
  • Seasonal trivalent inactivated influenza vaccine does not protect against newly emerging variants of influenza a (H3N2v) virus in ferrets.  87:1261-1263. 2013
  • The amino-terminal domain of alphavirus capsid protein is dispensable for viral particle assembly but regulates RNA encapsidation through cooperative functions of its subdomains.  87:12003-12019. 2013
  • Tropism and infectivity of influenza virus, including highly pathogenic avian H5N1 virus, in ferret tracheal differentiated primary epithelial cell cultures.  87:2597-2607. 2013
  • TLR7 Recognition is dispensable for influenza virus a infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice.  86:10988-10998. 2012
  • New PARP gene with an anti-alphavirus function.  86:8147-8160. 2012
  • Antibody-dependent cellular cytotoxicity against primary hivinfected CD4 + T cells is directly associated with the magnitude of surface igg binding.  86:8672-8680. 2012
  • Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate..  86:7256. 2012
  • Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication.  86:6835-6846. 2012
  • Early events in alphavirus replication determine the outcome of infection.  86:5055-5066. 2012
  • Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12.  86:5304-5313. 2012
  • Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge.  86:4234-4244. 2012
  • Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages.  86:2715-2728. 2012
  • Evolutionary dynamics of local pandemic H1N1/2009 influenza virus lineages revealed by whole-genome analysis.  86:11-18. 2012
  • Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: Possible involvement in the pathogenesis of human H5N1 virus infection.  86:667-678. 2012
  • Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection.  85. 2011
  • Ocular tropism of influenza a viruses: Identification of H7 subtype-specific host responses in human respiratory and ocular cells.  85:10117-10125. 2011
  • Conservation of a packaging signal and the viral genome RNA packaging mechanism in alphavirus evolution..  85:8022-8036. 2011
  • A role for the small GTPase Rab6 in assembly of human cytomegalovirus.  85:5213-5219. 2011
  • Design of chimeric alphaviruses with a programmed, attenuated, cell type-restricted phenotype.  85:4363-4376. 2011
  • Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.  85:5027-5035. 2011
  • Access to RNA encapsidated in the nucleocapsid of vesicular stomatitis virus.  85:2714. 2011
  • Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers.  85:2316-2324. 2011
  • The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells (Journal of Virology (2005) 79, 4, (2261-2273)).  85:3041. 2011
  • Pathogenesis and transmission of triple-reassortant swine H1N1 influenza viruses isolated before the 2009 H1N1 pandemic.  85:1563-1572. 2011
  • Higher level of replication efficiency of 2009 (H1N1) pandemic influenza virus than those of seasonal and avian strains: Kinetics from epithelial cell culture and computational modeling.  85:1125. 2011
  • The 2009 pandemic H1N1 and triple-reassortant swine H1N1 influenza viruses replicate efficiently but elicit an attenuated inflammatory response in polarized human bronchial epithelial cells.  85:686-696. 2011
  • Immature and Transitional B Cells Are Latency Reservoirs for a Gammaherpesvirus.  84:13045-13052. 2010
  • NFAT and CREB regulate Kaposi's sarcoma-associated herpesvirus-induced cyclooxygenase 2 (COX-2)..  84:12733. 2010
  • Vaccinia virus D4 mutants defective in processive DNA synthesis retain binding to A20 and DNA.  84:12325-12335. 2010
  • Crystallographic structure of porcine adenovirus type 4 fiber head and galectin domains.  84. 2010
  • Hit-and-run stimulation: A novel concept to reactivate latent HIV-1 infection without cytokine gene induction.  84:8712-8720. 2010
  • Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection.  84. 2010
  • Use of a Virus-Encoded Enzymatic Marker Reveals that a Stable Fraction of Memory B Cells Expresses Latency-Associated Nuclear Antigen throughout Chronic Gammaherpesvirus Infection.  84. 2010
  • Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice.  84:4194. 2010
  • Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination.  84:4998-5006. 2010
  • Venezuelan equine encephalitis virus capsid protein forms a tetrameric complex with CRM1 and importin α/β that obstructs nuclear pore complex function.  84:4158-4171. 2010
  • Bicaudal D1-dependent trafficking of human cytomegalovirus tegument protein pp150 in virus-infected cells.  84. 2010
  • Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.  84:2610-2617. 2010
  • Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles..  83:12680-12691. 2009
  • Targeted transduction via CD4 by a lentiviral vector uses a clathrin-mediated entry pathway.  83:13026-13031. 2009
  • Characterization of a mumps virus nucleocapsidlike particle.  83:11402. 2009
  • Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human t cells.  83:11283-11297. 2009
  • Structural and functional elements of the promoter encoded by the 5′ untranslated region of the Venezuelan equine encephalitis virus genome.  83:8327-8339. 2009
  • Reassortment between avian H5N1 and human H3N2 influenza viruses in ferrets: A public health risk assessment.  83:8131-8140. 2009
  • Ocular infection of mice with influenza A (H7) viruses: A site of primary replication and spread to the respiratory tract.  83:7075-7084. 2009
  • Early control of H5N1 influenza virus replication by the type I interferon response in mice.  83:5825-5834. 2009
  • Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.  83:5726-5734. 2009
  • Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency.  83:3078. 2009
  • Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection.  83:3258-3267. 2009
  • Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: Antiviral potential of exogenous alpha interferon to reduce virus shedding.  83:2851-2861. 2009
  • Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma.  83:1240-1259. 2009
  • Passive immunization reduces murine cytomegalovirus-induced brain pathology in newborn mice.  82. 2008
  • Structural Determinant of Human La Protein Critical for Internal Initiation of Translation of Hepatitis C Virus RNA.  82. 2008
  • Different types of nsP3-containing protein complexes in sindbis virus-infected cells.  82:10088-10101. 2008
  • The quality of chimpanzee T-cell activation and simian immunodeficiency virus/human immunodeficiency virus susceptibility achieved via antibody-mediated T-cell receptor/CD3 stimulation is a function of the anti-CD3 antibody isotype.  82:10271-10278. 2008
  • Analysis of natural sequence variation and covariation in human immunodeficiency virus type 1 integrase.  82:9228-9235. 2008
  • A new role for ns polyprotein cleavage in Sindbis virus replication.  82:6218-6231. 2008
  • Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration.  82:6458-6469. 2008
  • Multimerization of tegument protein pp28 within the assembly compartment is required for cytoplasmic envelopment of human cytomegalovirus.  82:6272-6287. 2008
  • Human immunodeficiency virus type 1 Vpr binds to the N lobe of the Wee1 kinase domain and enhances kinase activity for Cdc2.  82:5672-5682. 2008
  • Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection.  82:3295. 2008
  • Venezuelan equine encephalitis virus capsid protein inhibits nuclear import in mammalian but not in mosquito cells.  82:4028-4041. 2008
  • Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.  81:12608-12618. 2007
  • Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type I interferon response in polarized human bronchial epithelial cells.  81:12439. 2007
  • Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.  81:10869-10878. 2007
  • Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: Enhanced virulence of eurasian H7N7 viruses isolated from humans.  81:11139-11147. 2007
  • The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses.  81. 2007
  • The cytoplasmic tail of glycoprotein M (gpUL100) expresses trafficking signals required for human cytomegalovirus assembly and replication.  81:10316-10328. 2007
  • Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire.  81:9331-9338. 2007
  • Dynein-dependent transport of the Hantaan virus nucleocapsid protein to the endoplasmic reticulum-Golgi intermediate compartment.  81:8634-8647. 2007
  • Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.  81:7238-7248. 2007
  • Cytoplasmic envelopment of human cytomegalovirus requires the postlocalization function of tegument protein pp28 within the assembly compartment.  81:6536-6547. 2007
  • Human serum amyloid A protein inhibits hepatitis C virus entry into cells..  81:6128-6133. 2007
  • Mitogen-activated protein kinases activate the nuclear localization sequence of human papillomavirus type 11 E1 DNA helicase to promote efficient nuclear import.  81:5066-5078. 2007
  • Novel nuclear import of Vpr promoted by importin a is crucial for human immunodeficiency virus type 1 replication in macrophages.  81:5284-5293. 2007
  • The carboxy-terminal domain of glycoprotein N of human cytomegalovirus is required for virion morphogenesis.  81:5212-5224. 2007
  • Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: Implications for clinical efficacy.  81:3272-3284. 2007
  • Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding.  81:4348-4356. 2007
  • The old world and new world alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.  81:2472-2484. 2007
  • Notch1 augments intracellular trafficking of adeno-associated virus type 2.  81:2069-2073. 2007
  • The unique C termini of orthopoxvirus gamma interferon binding proteins are essential for ligand binding.  80. 2006
  • Complementation of human immunodeficiency virus type 1 replication by intracellular selection of Escherichia coli tRNA3Lys supplied in trans.  80:9641-9650. 2006
  • Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.  80:8909-8919. 2006
  • Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities..  80:7364-7374. 2006
  • Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription.  80:5686-5696. 2006
  • Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus.  80:4792-4800. 2006
  • Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels.  80:3732. 2006
  • Crystal structure of the oligomerization domain of the phosphoprotein of vesicular stomatitis virus.  80:2808-2814. 2006
  • Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: Effects of highly active antiretroviral therapy provide insights into the mechanisms of naïve T-cell depletion.  80:2665-2674. 2006
  • Human cytomegalovirus UL97 kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis.  79:15494-15502. 2005
  • Herpes simplex virus type 1 glycoprotein E is required for axonal localization of capsid, tegument, and membrane glycoproteins.  79. 2005
  • Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells..  79:13963-13973. 2005
  • Rapid recruitment of virus-specific CD8 T cells restructures immunodominance during protective secondary responses.  79:12703-12713. 2005
  • Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals.  79:11788-11800. 2005
  • Deletion of gpUL132, a structural component of human cytomegalovirus, results in impaired virus replication in fibroblasts..  79:11837-11847. 2005
  • Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies.  79:10108-10125. 2005
  • Structural elements of the tRNA TψC loop critical for nucleocytoplasmic transport are important for human immunodeficiency virus type 1 primer selection.  79:6532-6539. 2005
  • Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.  79:4066-4079. 2005
  • Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001.  79:4201-4212. 2005
  • Characterization of highly pathogenic H5N1 avian influenza a viruses isolated from South Korea.  79:3692-3702. 2005
  • Importin-α promotes passage through the nuclear pore complex of human immunodeficiency virus type 1 Vpr.  79:3557-3564. 2005
  • The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells.  79:2261-2273. 2005
  • Cyclin/CDK regulates the nucleocytoplasmic localization of the human papillomavirus E1 DNA helicase.  13954-13965. 2004
  • Experimental infection of NOD/SCID mice reconstituted with human CD34 + cells with Epstein-Barr virus.  13891-13900. 2004
  • Clonal selection for transcriptionally active viral oncogenes during progression to cancer.  11172-11186. 2004
  • Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system.  9041-9050. 2004
  • Evidence that stable retroviral transduction and cell survival following DNA integration depend on components of the nonhomologous end joining repair pathway 2004
  • An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.  7217-7226. 2004
  • Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.  7089-7096. 2004
  • Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus 2004
  • Postattachment events associated with viral entry are necessary for induction of interferon-stimulated genes by human cytomegalovirus.  6688-6691. 2004
  • Effects of mutations of the initiation nucleotides on hepatitis C virus RNA replication in the cell..  3633-3643. 2004
  • Analysis of the 3′ cis-Acting Elements of Rubella Virus by Using Replicons Expressing A Puromycin Resistance Gene.  2553-2561. 2004
  • Selection of Functional 5′ cis-Acting Elements Promoting Efficient Sindbis Virus Genome Replication.  61-75. 2004
  • The Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 N Terminus Is Essential for Chromosome Association, DNA Replication, and Episome Persistence 2004
  • mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication.  77:10213-10226. 2003
  • Selection of retroviral reverse transcription primer is coordinated with tRNA biogenesis.  77:8695. 2003
  • Delivery of adeno-associated virus vectors to the fetal retina: Impact of viral capsid proteins on retinal neuronal progenitor transduction.  77:7957-7963. 2003
  • Activation of adenovirus early promoters and lytic phase in differentiated strata of organotypic cultures of human keratinocytes.  77:6533-6540. 2003
  • Foamy virus envelope glycoprotein is sufficient for particle budding and release.  77:2338-2348. 2003
  • A P22 scaffold protein mutation increases the robustness of head assembly in the presence of excess portal protein..  76:10245-10255. 2002
  • Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency.  76:8776-8786. 2002
  • Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1.  76:8276-8284. 2002
  • Human immunodeficiency virus-specific CD8+ T cells in human breast milk.  76:7365-7373. 2002
  • Kinetic analysis of the role of intersubunit interactions in human immunodeficiency virus type 1 capsid protein assembly in vitro..  76:6900-6908. 2002
  • Hepatic DR5 induces apoptosis and limits adenovirus gene therapy product expression in the liver.  76. 2002
  • Pathogenesis of avian influenza A (H5N1) viruses in ferrets.  76. 2002
  • The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.  76:4331-4340. 2002
  • Alternative fates of keratinocytes transduced by human papillomavirus type 18 E7 during squamous differentiation.  76:2964-2972. 2002
  • ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.  76:292-302. 2002
  • Cervicovaginal lamina propria lymphocytes: Phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251.  76:9-18. 2002
  • Roles of nonstructural protein nsP2 and alpha/beta interferons in determining the outcome of Sindbis virus infection.  76:11254-11264. 2002
  • Second-site mutation outside of the Us10-12 domain of δγ134.5 Herpes simplex virus 1 recombinant blocks the shutoff of protein synthesis induced by activated protein kinase r and partially restores neurovirulence.  76:942-949. 2002
  • Impairment of Gag-specific CD8+ T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques.  75:11483-11495. 2001
  • Moloney murine leukemia virus integrase protein augments viral DNA synthesis in infected cells.  75:11365-11372. 2001
  • Palmitoylation of the Rous sarcoma virus transmembrane glycoprotein is required for protein stability and virus infectivity.  75:11544. 2001
  • Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines.  75:11474-11482. 2001
  • Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus.  75:10746-10754. 2001
  • Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: Implications for ex vivo immunotherapy.  75:9493-9501. 2001
  • Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.  75:8681-8689. 2001
  • Human papillomavirus E6E7-mediated adenovirus cell killing: Selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes.  75:7602-7611. 2001
  • In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb.  75:5099-5107. 2001
  • Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza a H5N1 virus infection.  75:5141-5150. 2001
  • Identification of critical elements in the tRNA acceptor stem and TψC loop necessary for human immunodeficiency virus type 1 infectivity.  75:4902-4906. 2001
  • Immunity to influenza A H9N2 viruses induced by infection and vaccination.  75. 2001
  • Dissemination and pathology of simian immunodeficiency virus PBj14 early after rectal infection of pig-tailed macaques.  75:278-91. 2001
  • Inherent instability of poliovirus genomes containing two internal ribosome entry site (IRES) elements supports a role for the IRES in encapsidation.  74:8335-8342. 2000
  • Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.  74:8358-8367. 2000
  • Two putative α-helical domains of human immunodeficiency virus type 1 Vpr mediate nuclear localization by at least two mechanisms.  74:7179-7186. 2000
  • A carboxy-terminally truncated form of the human immunodeficiency virus type 1 Vpr protein induces apoptosis via G1 cell cycle arrest.  74:6058-6067. 2000
  • Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans.  74:6105-6116. 2000
  • Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.  74:5495-5501. 2000
  • Protective immunity to rotavirus shedding in the absence of interleukin- 6: Th1 cells and immunoglobulin A develop normally.  74:5250-5256. 2000
  • Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endoplasmic reticulum-Golgi-intermediate compartment.  74:3842-3851. 2000
  • Identification of additional coat-scaffolding interactions in a bacteriophage P22 mutant defective in maturation.  74:3871-3873. 2000
  • The hinge of the human papillomavirus type 11 E2 protein contains major determinants for nuclear localization and nuclear matrix association.  74:3761-3770. 2000
  • Characterization of the R572T point mutant of a putative cleavage site in human foamy virus env.  74:2949-2954. 2000
  • A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon.  74:10249-10255. 2000
  • De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus..  74:851-863. 2000
  • Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 Tat in astrocytes.  74:9214-9221. 2000
  • Study of the assembly of vesicular stomatitis virus N protein: Role of the P protein.  74:9515. 2000
  • Adeno-associated virus type 2-mediated gene transfer: Role of epidermal growth factor receptor protein tyrosine kinase in transgene expression.  72:9835-9843. 1998
  • An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor- independent cell entry mechanism.  72:9706-9713. 1998
  • Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.  72:2483-2490. 1998
  • Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob.  72. 1998
  • Influenza virus-infected epithelial cells present viral antigens to antigen-specific CD8+ cytotoxic T lymphocytes.  72:4534-4536. 1998
  • Localization of human cytomegalovirus structural proteins to the nuclear matrix of infected human fibroblasts.  72:3321-3329. 1998
  • Membrane organization of bluetongue virus nonstructural glycoprotein NS3.  72:3362-3369. 1998
  • Preferential completion of human immunodeficiency virus type 1 proviruses initiated with tRNA3/(Lys) rather than tRNA1,2/(Lys).  72:5464-5471. 1998
  • Recombinant human parvovirus B19 vectors: Erythroid cell-specific delivery and expression of transduced genes.  72:5224-5230. 1998
  • The carboxyl-terminal region of the human papillomavirus type 16 E1 protein determines E2 protein specificity during DNA replication.  72:3436-3441. 1998
  • A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum.  71:778-784. 1997
  • Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo.  71:3098. 1997
  • Encapsidation of adeno-associated virus type 2 rep proteins in wild- type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells.  71:7361-7371. 1997
  • Identification of a Sequence within U5 Required for Human Immunodeficiency Virus Type 1 to Stably Maintain a Primer Binding Site Complementary to tRNAMet.  71:207-217. 1997
  • Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.  71:7704. 1997
  • Nucleotide substitutions within U5 are critical for efficient reverse transcription of human immunodeficiency virus type 1 with a primer binding site complementary to tRNA.  71:6315-6322. 1997
  • Packaging Signals in Alohaviruses.  71:248-258. 1997
  • Sindbis virus replicons and sindbis virus: Assembly of chimeras and of particles deficient in virus RNA.  71:2819-2829. 1997
  • Virus-specific, CD8+ major histocompatibility complex class I- restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus- infected β2-microglobulin-deficient mice.  71:8392-8396. 1997
  • Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNAHis.  70. 1996
  • Efficient initiation and strand transfer of polypurine tract-primed plus-strand DNA prevent strand transfer of internally initiated plus-strand DNAs.  70. 1996
  • Endogenous reverse transcription assays reveal high-level resistance to the triphosphate of (-)2'-dideoxy-3'-thiacytidine by mutated M184V human immunodeficiency virus type 1.  70:5642-5645. 1996
  • Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.  70:3378. 1996
  • Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 gag.  70:2643. 1996
  • Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: Selective encapsidation of viral genomes in progeny virions.  70:1668-1677. 1996
  • Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions.  69:1540-1547. 1995
  • An aspartic acid at amino acid 108 is required to rescue infectious virus after transfection of a poliovirus cDNA containing a CGDD but not SGDD amino acid motif in 3D(pol).  69. 1995
  • Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase.  69:1359-1366. 1995
  • Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA3/(Lys).  69:6021-6029. 1995
  • In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease.  69:5228-5235. 1995
  • Mutation of the aspartic acid residues of the GDD sequence motif of poliovirus RNA-dependent RNA polymerase results in enzymes with altered metal ion requirements for activity.  69. 1995
  • Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.  69:3389-3398. 1995
  • Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2.  69:8096-8101. 1995
  • Analysis of the primary T-cell response to Sendai virus infection in C57BL/6 mice: CD4+ T-cell recognition is directed predominantly to the hemagglutinin-neuraminidase glycoprotein.  68:6863-6870. 1994
  • Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.  68:1115-1127. 1994
  • In vitro characterization of an internal ribosomal entry site (IRES) present within the 5' nontranslated region of hepatitis A virus RNA: Comparison with the IRES of encephalomyocarditis virus.  68:1066-1074. 1994
  • Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.  68:6161-6169. 1994
  • Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site.  68:1605-1614. 1994
  • Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins.  66:5224-5231. 1992
  • Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts.  66:1129-1138. 1992
  • In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome.  66:6806-6812. 1992
  • Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.  66:4556-4563. 1992
  • Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).  66:6747-6754. 1992
  • The nonmyristylated Pr160(gag-pol) polyprotein of human immunodeficiency virus type 1 interacts with Pr55(gag) and is incorporated into viruslike particles.  66:6304-6313. 1992
  • An E1M E2C fusion protein encoded by human papillomavirus type 11 is a sequence-specific transcription repressor.  65:3317-3329. 1991
  • Deletions in the tRNA(Lys) primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription.  65:4555-4564. 1991
  • Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons.  65:2875-2883. 1991
  • Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production.  65:5111-5117. 1991
  • Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus.  64. 1990
  • Human papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar warts.  64:3144-3149. 1990
  • Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice.  64. 1990
  • Evidence for interference, coinfections, and intertypic virus enhancement of infection by ovine-caprine lentiviruses.  63:4682-4688. 1989
  • Modulation of lentivirus replication by antibodies: Fc portion of immunoglobulin molecule is essential for enhancement of binding internalization, and neutralization of visna virus in macrophages.  63:1811-1813. 1989
  • Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.  63:403-410. 1989
  • Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIV(MAC).  62:3501. 1988
  • Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB).  62:3309-3318. 1988
  • Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: Functional and biochemical studies.  62:2994. 1988
  • Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata.  61:2581-2588. 1987
  • Identification and mapping of human papillomavirus type 1 RNA transcripts recovered from plantar warts and infected epithelial cell cultures.  61:1913-1918. 1987
  • Isolation of mycoplasma virus L2 insertion variants and miniviruses.  59:584-590. 1986
  • Effect of cloned human interferons on protein synthesis and morphogenesis of herpes simplex virus.  56:419-425. 1985
  • Morphogenesis of bacteriophage phi29 of Bacillus subtilis: Prohead restoration for DNA-gp3 packaging and assembly.  53:858-861. 1985
  • ATP is required for initiation of poliovirus RNA synthesis in vitro: Demonstration of tyrosine-phosphate linkage between in vitro-synthesized RNA and genome-linked protein.  50:515-523. 1984
  • Bacteriophage φ29 proteins required for in vitro DNA-gp3 packaging.  50:766-772. 1984
  • Amino-terminal amino acid sequence of p10, the fifth major gag polypeptide of avian sarcoma and leukemia viruses.  45. 1983
  • Morphogenesis of bacteriophage φ29 of Bacillus subtilis: Oriented and quantized in vitro packaging of DNA protein gp3.  45:383-396. 1983
  • Selective dansylation of M protein within intact influenza virions.  44:871-876. 1982
  • Structure of the membrane protein of influenza virus. I. Isolation and characterization of cyanogen bromide cleavage products.  30:759-766. 1979
  • A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans.  73:5903-5911.
  • An E1M--E2C fusion protein encoded by human papillomavirus type 11 is asequence-specific transcription repressor..  65:3317-3329.
  • An Early Stage of Mason-Pfizer Monkey Virus Budding Is Regulated by the Hydrophobicity of the Gag Matrix Domain Core.  5023-5031.
  • Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription.  81:13552-13565.
  • Better viral control despite higher CD4+ T cell activation during acute HIV-1 infection in Zambian women is linked to the sex hormone estradiol.  94.
  • Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes.  82.
  • Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.  67:3684-3690.
  • Enzymatic activity of poliovirus RNA polymerases with mutations at the tyrosine residue of the conserved YGDD motif: Isolation and characterization of polioviruses containing RNA polymerases with FGDD and MGDD sequences.  67:373-381.
  • Functional sindbis virus replicative complexes are formed at the plasma membrane.  84:11679-11695.
  • Genetic analysis of a unique human immunodeficiency virus type 1 (HIV- 1) with a primer binding site complementary to tRNA(Met) supports a role for U5-PBS stem-loop RNA structures in initiation of HIV-1 reverse transcription.  73:1818-1827.
  • Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes.  82:5054.
  • Incomplete downregulation of CD4 expression affects HIV-1 Env conformation and antibody-dependent cellular cytotoxicity responses..  92.
  • Infectivity studies of influenza virus hemagglutinin receptor binding site mutants in mice.  82:5079-5083.
  • Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.  75:3250-3258.
  • Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in mammalian cells.  79:7597-7608.
  • Novel mutations in NSP2 abolish Chikungunya virus-induced transcriptional shutoff and make the virus less cytopathic without affecting its replication rates.  93.
  • Poliovirus capsid proteins derived from P1 precursors with glutamine- valine cleavage sites have defects in assembly and RNA encapsidation.  67:7284-7297.
  • Productive replication of human adenovirus type 5 in canine cells.  79:1308.
  • Regulation of the human papillomavirus type 11 E6 promoter by viral and host transcription factors in primary human keratinocytes.  67:1721-1726.
  • Robust human and murine hepatocyte culture models of hepatitis B virus infection and replication.  92.
  • Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells.  73:3854-3865.
  • Sindbis virus expression vectors: Packaging of RNA replicons by using defective helper RNAs.  67:6439-6446.
  • Sindbis virus infection causes cell death by NSP2-induced transcriptional shutoff or by Nsp3-dependent translational shutoff.  92.
  • Sindbis virus with a tricomponent genome.  79:637.
  • Wide variation in the multiplicity of HIV-1 infection among injection drug users.  84.
  • International Standard Serial Number (issn)

  • 0022-538X